Error loading player: No playable sources found

3385

DDW The Evolving Role of the Gastroenterologist for Detecting, Managing, and Preventing IBD-Related Dysplasia and CRC

Date
May 7, 2023
Explore related products in the following collection:

Society: DDW

LIVE STREAM SESSION

Moderators

Speaker Image for David Rubin
University of Chicago Division of the Biological Sciences
Speaker Image for Nayantara Coelho-Prabhu
Mayo Clinic Rochester

Related Products

Thumbnail for THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
Thumbnail for AGA The Mucosal Immune Response and Nonimmune Cells in IBD
AGA The Mucosal Immune Response and Nonimmune Cells in IBD
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…